Camrelizumab, Apatinib Plus HAIC Versus Camrelizumab and Apatinib for HCC With Portal Vein Invasion: a Randomized Trial
Clinical trial NCT05198609 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05198609
- Sponsor
- Sun Yat-sen University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-17
- Primary completion
- 2026-07-01
- Enrollment
- 214
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.